Literature DB >> 2432162

Correlation of serotype specificity and protein structure of the five U.S. serotypes of bluetongue virus.

J O Mecham, V C Dean, M M Jochim.   

Abstract

The relationship between serotype specificity and protein structure was studied by polyacrylamide gel electrophoresis, peptide mapping and radioimmune precipitation (RIP) of structural and non-structural proteins of the five U.S. serotypes of bluetongue virus (BTV). The surface proteins, VP2 and VP5, showed the most variation in size among the serotypes. Peptide mapping of the proteins showed that VP2 is unique for each of the U.S. serotypes. The nucleocapsid and non-structural proteins showed a high degree of conservation, whereas the other surface protein, VP5, showed intermediate conservation among the serotypes. Monospecific neutralizing antiserum produced in rabbits against each serotype was used in cross-RIP against cytoplasmic extracts prepared from cells infected with each BTV serotype. There were extensive cross-reactions among those proteins which showed a high degree of structural conservation, whereas VP2 was immunoprecipitated best in the homologous RIP system. Thus, a correlation between serotype specificity and protein structure was shown among the five U.S. serotypes of BTV.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2432162     DOI: 10.1099/0022-1317-67-12-2617

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  7 in total

1.  VP2 is the major exposed protein on orbiviruses.

Authors:  S A Lewis; M J Grubman
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

2.  Purification, stability, and immunogenicity analyses of five bluetongue virus proteins for use in development of a subunit vaccine that allows differentiation of infected from vaccinated animals.

Authors:  Jenna Anderson; Emmanuel Bréard; Karin Lövgren Bengtsson; Kjell-Olov Grönvik; Stéphan Zientara; Jean-Francois Valarcher; Sara Hägglund
Journal:  Clin Vaccine Immunol       Date:  2014-01-22

3.  Epizootic hemorrhagic disease: analysis of tissues by amplification and in situ hybridization reveals widespread orbivirus infection at low copy numbers.

Authors:  S J Brodie; K D Bardsley; K Diem; J O Mecham; S E Norelius; W C Wilson
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Topography and immunogenicity of bluetongue virus VP7 epitopes.

Authors:  L F Wang; A D Hyatt; P L Whiteley; M Andrew; J K Li; B T Eaton
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

5.  Identification of a neutralizing epitope shared by bluetongue virus serotypes 2 and 13.

Authors:  S Ristow; L Leendersten; J Gorham; T Yilma
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

6.  Evaluation of the immunogenicity of an experimental subunit vaccine that allows differentiation between infected and vaccinated animals against bluetongue virus serotype 8 in cattle.

Authors:  Jenna Anderson; Sara Hägglund; Emmanuel Bréard; Loic Comtet; Karin Lövgren Bengtsson; John Pringle; Stéphan Zientara; Jean Francois Valarcher
Journal:  Clin Vaccine Immunol       Date:  2013-05-29

7.  Bioinformatic analysis suggests that the Orbivirus VP6 cistron encodes an overlapping gene.

Authors:  Andrew E Firth
Journal:  Virol J       Date:  2008-04-14       Impact factor: 4.099

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.